Where science becomes product, channel, and market.
H2 Wellness Hub is a business-first watch for the molecular-hydrogen field. We connect the people building brands, products, channels, standards, and commercial cases with the external resources that help them make better decisions.
We use Hydrogen Wellness Industry for the product, channel, quality, and market category. Healthcare is reserved for hospital, clinical-research, and regulatory contexts. We follow commercial signals, point to credible resources, and collect cases that reveal how the category is actually being built.
01 / Industry Pulse
Commercial signals worth tracking.
Short, source-linked updates on market structure, retail, partnerships, and responsible industry infrastructure.
The American Hydrogen Health Association launched as a voluntary industry council focused on transparency, scientific guidance, testing, labeling, and responsible marketing. The business signal is category self-organization, not government certification.
Source: AHHA launch announcement · Industry association
Echo announced an iCRYO partnership that places branded hydrogen-water stations and portable products in participating centers. It is a channel case: a device category becomes part of a wellness-service environment.
Source: company partnership announcement · Commercial case
Following a local pilot, oHy announced broader Midwest placement at Meijer. The case is relevant for teams studying how hydrogen moves from a device-led category into functional-beverage retail.
Source: company distribution announcement · Retail expansion
02 / Resource Desk
Academic sources and tools behind the field.
Experts, research institutions, long-running knowledge sources, publications, patents, trials, standards, and testing tools live here as links to the organizations that maintain them.
Industry cases across products, channels, and institutions.
Research-to-market programs, enterprises, products, channels, and applications selected for a specific industry lesson, not an unqualified health claim.
A university center positioning hydrogen medicine as translational infrastructure across medicine, engineering, and veterinary science. The lesson is the bridge between research, device development, and real-world implementation.
A multicenter Japanese study with registry linkage, defined protocol, and published results. It ended early and its primary endpoint was not statistically significant: a transparency case, not a universal efficacy claim.
A hydrogen-water brand moving beyond direct sales into a recovery-service channel, where station design, staff education, repeat use, and in-center retail matter alongside the device.
A company-reported retail expansion that shows a possible route from device-led hydrogen formats into packaged functional-beverage shelves. Distribution claims remain company sourced.
A device-launch and direct-retail case. Its relevance is product positioning, retail communication, and service design; performance language should remain attributed to the company.
A useful product-operations case for examining service, replacement, maintenance, and ownership experience. A product announcement does not establish clinical utility.
A portable-device and app-integration case. It is useful for studying user interaction and form factor; regulatory status must always be checked by market and intended use.
A crowdfunding/company-release example of a portability-led format. Treat it as a market-format signal rather than independent validation of product performance.
A company guide creates a useful prompt for examining package, storage, and dissolved-hydrogen retention communication. Those claims remain company claims unless independently checked.
A H2 Wellness Hub Casebook analysis of how a voluntary association frames testing, labeling, and responsible marketing in a young category. The original launch announcement is linked in the article’s source card.
MUQI Technology is one player among the cases tracked by this Hub. This disclosed internal case examines its solid-state hydrogen materials and functional ceramics through material, product, channel, and use-case lenses rather than as a category-wide conclusion.
A registered hospital study examining 2% inhaled hydrogen alongside standard care after extracorporeal CPR. It is a useful case of how a high-risk clinical protocol is built around a defined dose, timeline, and trial endpoint. The study is recruiting; registration does not establish efficacy or a consumer-wellness use.
A completed early-phase hospital study of a low-concentration hydrogen/nitrogen mixture in hospitalized COVID-19 patients. Its industry lesson is safety engineering and protocol discipline in a medical-gas setting, not evidence for a general wellness claim or a consumer device.
A small registered, double-blind hospital trial of inhaled hydrogen in ulcerative colitis. It illustrates a chronic-disease research pathway with a defined protocol and endpoint. It must not be used to claim that hydrogen treats ulcerative colitis or to support a wellness-product claim.
A H2 Wellness Hub reading of a registered crossover study in healthy adults. The article unpacks the protocol, measures, research status, and what a registry cannot establish; its source card links to UMIN.
A Japanese consumer-device line combining hydrogen inhalation and hydrogen-water generation. The case is useful for studying product architecture, specifications, and category positioning. Company information does not establish clinical performance, regulatory clearance, or a health outcome.
A completed, registered double-blind crossover study. Its Casebook value is methodological: gas purity, flow, placebo design, and sample size are visible in the registry rather than buried in a marketing claim. No results were posted to the record at review.
A completed, registered trial comparing 0.9 ppm hydrogen water with placebo in an exercise context. It highlights the operational fields a responsible product study should make visible: concentration, comparator, timing, and outcome. Completion does not mean a result or consumer claim has been established.
A Brazilian supplier’s portable molecular-hydrogen bottle is a market-supply signal for Latin America. The useful questions are technical route, warranty, service, and independent testing access. Product specifications and effects remain company statements unless corroborated.
21
South Africa · Company-reported packaged-water case
A South African company describes a packaging-stage hydrogen-infusion process. It provides a useful prompt for investigating traceability, retention testing, and food-production controls in a ready-to-drink format. Manufacturing and quality statements remain supplier claims pending independent verification.